Swiftmerge Acquisition Corp. (IVCP)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 10.75 |
| Open | 10.80 |
| Bid | 10.80 x 100 |
| Ask | 10.85 x 100 |
| Day's range | 10.79 - 10.79 |
| 52-week range | 10.00 - 12.20 |
| Volume | |
| Avg. volume | 17,283 |
| Market cap | 73.803M |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | 49.05 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
NEW YORK & VERO BEACH, Fla., August 11, 2023--HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ: IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer
© 2024 Yahoo. All rights reserved.